It’s the latest move by pharmacy benefit managers, which negotiate drug prices on behalf of health plans, to deal with the surging demand for weight-loss medicines. The copay option would take effect starting next year.
The drugs are expensive, so insurers have pushed back against covering them. That’s left patients facing list prices that top $1,000 a month, though manufacturers have set up ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.